Investing.com - Financial Markets Worldwide

Cardinal Health CAO Scherer sells $1m in shares

Published 20/08/2025, 00:32
Cardinal Health CAO Scherer sells $1m in shares
CAH
1.68%

Cardinal Health Inc (NASDAQ:NYSE:CAH), a prominent healthcare provider with a market capitalization of $35.6 billion, saw Chief Accounting Officer Mary C. Scherer sell 6,766 shares of company stock on August 19, 2025, at prices ranging from $148.94 to $149.60, for a total value of $1,009,825. InvestingPro analysis indicates the stock is currently undervalued, with analyst price targets ranging from $150 to $203.

According to a Form 4 filing with the Securities and Exchange Commission, Scherer also had 2,572 shares withheld to cover tax obligations related to the vesting of restricted share units and performance share units. The shares were valued at $150.22, for a total value of $386,365. The company, known for its 43-year track record of consistent dividend payments, has demonstrated strong price stability with a beta of 0.68.

On August 15, 2025, Scherer was granted 1,203 restricted share units that will vest in three equal annual installments beginning August 15, 2026. Discover more insights about Cardinal Health’s financial health and growth potential with a comprehensive Pro Research Report, available exclusively on InvestingPro.

In other recent news, Cardinal Health reported its fourth-quarter earnings for fiscal 2025, revealing mixed results. The company achieved earnings per share of $2.08, slightly exceeding the anticipated $2.03. However, revenue fell short of expectations, coming in at $60.2 billion compared to the forecasted $60.92 billion. Additionally, Cardinal Health announced a $1 billion public offering of senior notes in two tranches, with $600 million in 4.500% notes due 2030 and $400 million in 5.150% notes due 2035. The offering is underwritten by Goldman Sachs, BofA Securities, and Wells Fargo (NYSE:WFC) Securities. Furthermore, the company’s Board of Directors has approved a quarterly dividend of $0.5107 per share, payable to shareholders of record as of October 1, 2025. These developments highlight Cardinal Health’s recent financial activities and strategic decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.